Boston Scientific to Buy BTG for $4.2 Billion for Device Growth
Swedish Orphan Biovitrum AB, also gained the right to share the U.S. profits and losses on a potential new medicine.
Deal will help it develop faster-growing premium drinks in its U.S. portfolio: Diageo
Ebola Eludes Drug Testing Once More as Outbreak Tapers Off
New U.S. Trade Deal May Bring Higher Drug Prices to U.K.
Deadly Ebola Outbreak May Open Door to Finding Drugs That Work
Takeda's Credit Rating Cut by Moody's on $62 Billion Shire Deal
Danone Sells Yakult Shares at Discount, Raising $1.66 Billion
Stada Names Sandoz Manager as Fifth Chief Executive Since 2016
Bill & Melinda Gates Foundation to work with China’s health regulator to improve standard.
Home Depot to Upgrade Stores as It Pursues $120 Billion in Sales
Bristol-Myers Cancer Drug Opdivo Shows Surprising HIV Impact
Sanofi Says Dengue Vaccine Only Helps Those With Prior Infection
Humana Prepares to Cut Jobs as Insurer Boosts Outlook
Spire Rejects Offer From Shareholder Mediclinic as Too Low
Peanut Allergy Patch Fails Major Test, Sinking DBV's Stock
U.K. Charity to Use Funds From Blockbuster Drug to Back Research
Glaxo to Pay First Woman CEO Less, Citing a Lack of Experience
Roche Fights Roche in Bid to Preserve $9 Billion Drug Business
GW Pharma Plans to Cancel U.K. Listing in Favor of Nasdaq
Pfizer Won’t Pursue Splitting in Two Separate Units